KDR and neoplasm: Immunostaining, to determine whether tumor inhibition could be explained by disrupted VEGFR2 phosphorylation in LLC tumor endothelium, showed reduced VEGFR2 tyrosine phosphorylation in tumors from Vegfr2Cre/+ mice (Fig. 3b,c).